This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Public advisory

Unauthorized drug (Lite Fit USA) being sold in Canada

Starting date:
May 16, 2014
Posting date:
May 16, 2014
Type of communication:
Natural health products
Source of recall:
Health Canada
Unauthorized products
General Public
Identification number:


One lot of Lite Fit USA (Lot Number 13165, Exp. 05/17) is being voluntarily recalled in the U.S. after analysis by the U.S. Food and Drug Administration revealed the lot contains the undeclared prescription drug sibutramine. Lite Fit USA is not authorized for sale in Canada, but Health Canada has confirmed that this lot was imported and sold by the retail store Hoang Oanh Sandwich, 7178 St. Denis, Montreal, Québec. The affected lot may also be available at other retail outlets or for purchase online. Products that contain sibutramine are not authorized for sale on the Canadian market due to an increased risk of heart attack and stroke.

LiteFit USA is promoted as a herbal diet supplement packaged in plastic bottles of 30 softgels (see photo below).

Products affected

  1. Lite Fit USA (Lot Number 13165).

What you should do

  • Read the label of the products you buy to verify that they have been assessed by Health Canada for safety, effectiveness and quality. Health products that have been authorized for sale by Health Canada will have an eight-digit Drug Identification Number (DIN), a Homeopathic Medicine Number (DIN-HM) or a Natural Product Number (NPN) on the label.
  • Contact your health care practitioner if you have any questions or concerns regarding the use of this product.
  • Report any adverse events using these products to Health Canada.

Who is affected

Canadians who either have used or purchased Lite Fit USA, lot number 13165.


Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side-effects such as heart attack and stroke. The product poses a risk to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of cardiovascular disease including coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also cause serious side-effects in pregnant or nursing women. Sibutramine can interact with other medications and herbal products and poses a risk of serotonin syndrome, a serious and potentially fatal event.

Health Canada has not received any adverse reactions reports associated with the use of this product.

Report health or safety concerns

  • Call toll-free at 1-866-234-2345
  • Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
(613) 957-2983

Public enquiries

(613) 957-2991
1-866 225-0709

What Health Canada is doing

Health Canada is contacting drug importers to prevent any further importation or distribution of Lite Fit USA in Canada. Health Canada is also working with Canada Border Service Agency to help prevent future importations of LiteFit USA.


Select thumbnail to enlarge - opens in a new window